NUVATION BIO INC's ticker is NUVB and the CUSIP is 67080N101. A total of 74 filers reported holding NUVATION BIO INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $720,963 | -15.5% | 246,905 | +5.3% | 0.20% | -12.1% |
| Q1 2024 | $853,362 | +212.0% | 234,440 | +29.4% | 0.22% | +183.5% |
| Q4 2023 | $273,494 | +1.9% | 181,122 | -9.5% | 0.08% | -7.1% |
| Q3 2023 | $268,304 | -25.3% | 200,227 | +0.3% | 0.08% | -21.3% |
| Q2 2023 | $359,152 | +19.1% | 199,529 | +9.8% | 0.11% | +13.7% |
| Q1 2023 | $301,571 | -14.2% | 181,669 | -0.8% | 0.10% | -22.1% |
| Q4 2022 | $351,684 | -9.8% | 183,169 | +5.3% | 0.12% | -12.2% |
| Q3 2022 | $390,000 | -25.4% | 173,946 | +7.9% | 0.14% | -22.8% |
| Q2 2022 | $523,000 | -33.3% | 161,266 | +8.2% | 0.18% | -23.1% |
| Q1 2022 | $784,000 | -34.3% | 149,074 | +6.2% | 0.23% | -23.0% |
| Q4 2021 | $1,193,000 | -22.3% | 140,322 | -9.1% | 0.30% | -18.3% |
| Q3 2021 | $1,535,000 | +36.9% | 154,427 | +28.2% | 0.37% | +47.0% |
| Q2 2021 | $1,121,000 | +7.9% | 120,432 | +21.1% | 0.25% | -11.2% |
| Q1 2021 | $1,039,000 | – | 99,424 | – | 0.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 15,247,340 | $49,401,000 | 15.77% |
| Aisling Capital Management LP | 2,541,009 | $8,233,000 | 5.87% |
| EDBI Pte Ltd | 1,270,504 | $4,116,000 | 3.82% |
| Ally Bridge Group (NY) LLC | 1,137,152 | $3,684,000 | 3.36% |
| Deep Track Capital, LP | 11,471,281 | $37,167,000 | 2.44% |
| EcoR1 Capital, LLC | 13,896,543 | $45,025,000 | 1.55% |
| Boxer Capital, LLC | 4,341,009 | $14,065,000 | 0.89% |
| Baupost Group | 10,418,194 | $33,755,000 | 0.50% |
| Redmile Group, LLC | 3,471,709 | $11,248,000 | 0.43% |
| 683 Capital Management, LLC | 1,766,657 | $5,724,000 | 0.40% |